Article
Randomized controlled trial of lymphoblastoid interferon alpha for chronic hepatitis C (comparison of 9-MU and 6-MU doses). IFN Treatment Group of Affiliated Hospitals of the Third Department of Internal Medicine at Nagoya University School of Medicine.
The American journal of gastroenterology - 1 Jan 1999
Yoshioka K, Yano M, Kusakabe A, Hirofuji H, Fuji A, Kuriki J, Arao M, Murase K, Kidokoro R, Kakumu S
Abstract excerpt
OBJECTIVE: We conducted a randomized controlled trial to compare the efficacy of two different dosages of lymphoblastoid interferon alpha (IFN) for the treatment of chronic hepatitis C. METHODS: Eighty-four patients with chronic hepatitis C were enrolled and randomly assigned into the two groups; group A was treated with 6 million units (MU) and group B with 9 MU daily for the first 2 wk, and then thrice weekly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.